Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Taysha Gene Therapies Inc (NASDAQ: TSHA) closed at $2.71 in the last session, down -1.45% from day before closing price of $2.75. In other words, the price has decreased by -$1.45 from its previous closing price. On the day, 5.62 million shares were traded.
Ratios:
We take a closer look at TSHA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.35 and its Current Ratio is at 5.35. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 80.57 while its Price-to-Book (P/B) ratio in mrq is 10.09.
Stock Price History:
Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is 40.32%, while the 200-Day Moving Average is calculated to be 39.03%.
Shares Statistics:
A total of 205.05M shares are outstanding, with a floating share count of 176.26M. Insiders hold about 17.89% of the company’s shares, while institutions hold 75.84% stake in the company.
